223 related articles for article (PubMed ID: 19772552)
1. Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging.
Huang HC; Chang PY; Chang K; Chen CY; Lin CW; Chen JH; Mou CY; Chang ZF; Chang FH
J Biomed Sci; 2009 Sep; 16(1):86. PubMed ID: 19772552
[TBL] [Abstract][Full Text] [Related]
2. Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy.
Ma Y; Tong S; Bao G; Gao C; Dai Z
Biomaterials; 2013 Oct; 34(31):7706-14. PubMed ID: 23871538
[TBL] [Abstract][Full Text] [Related]
3. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
4. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.
Roohi F; Lohrke J; Ide A; Schütz G; Dassler K
Int J Nanomedicine; 2012; 7():4447-58. PubMed ID: 22927759
[TBL] [Abstract][Full Text] [Related]
5. Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies.
Feng ST; Li H; Luo Y; Cai H; Dong Z; Fang Z; Shuai X; Li ZP
Curr Cancer Drug Targets; 2016; 16(6):551-60. PubMed ID: 27262319
[TBL] [Abstract][Full Text] [Related]
6. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
7. Folate‑targeted polymeric micelles loaded with superparamagnetic iron oxide as a contrast agent for magnetic resonance imaging of a human tongue cancer cell line.
Cui MY; Dong Z; Cai H; Huang K; Liu Y; Fang Z; Li X; Luo Y
Mol Med Rep; 2017 Nov; 16(5):7597-7602. PubMed ID: 28944881
[TBL] [Abstract][Full Text] [Related]
8. Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratios.
Tiffany M; Szoka FC
J Drug Target; 2016 Nov; 24(9):857-864. PubMed ID: 27600702
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment.
Quinto CA; Mohindra P; Tong S; Bao G
Nanoscale; 2015 Aug; 7(29):12728-36. PubMed ID: 26154916
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of PEG-coated iron oxide nanoparticles as blood pool tracers for preclinical magnetic particle imaging.
Khandhar AP; Keselman P; Kemp SJ; Ferguson RM; Goodwill PW; Conolly SM; Krishnan KM
Nanoscale; 2017 Jan; 9(3):1299-1306. PubMed ID: 28059427
[TBL] [Abstract][Full Text] [Related]
11. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.
Yue-Jian C; Juan T; Fei X; Jia-Bi Z; Ning G; Yi-Hua Z; Ye D; Liang G
Drug Dev Ind Pharm; 2010 Oct; 36(10):1235-44. PubMed ID: 20818962
[TBL] [Abstract][Full Text] [Related]
13. R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.
Kuhlpeter R; Dahnke H; Matuszewski L; Persigehl T; von Wallbrunn A; Allkemper T; Heindel WL; Schaeffter T; Bremer C
Radiology; 2007 Nov; 245(2):449-57. PubMed ID: 17848680
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.
Sterenczak KA; Meier M; Glage S; Meyer M; Willenbrock S; Wefstaedt P; Dorsch M; Bullerdiek J; Murua Escobar H; Hedrich H; Nolte I
BMC Cancer; 2012 Jul; 12():284. PubMed ID: 22784304
[TBL] [Abstract][Full Text] [Related]
15. A nanosized delivery system of superparamagnetic iron oxide for tumor MR imaging.
Lee ES; Lim C; Song HT; Yun JM; Lee KS; Lee BJ; Youn YS; Oh YT; Oh KT
Int J Pharm; 2012 Dec; 439(1-2):342-8. PubMed ID: 22959991
[TBL] [Abstract][Full Text] [Related]
16. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Activity Measurements of Brown Adipose Tissue at 7 T Magnetic Resonance Imaging After Application of Triglyceride-Rich Lipoprotein 59Fe-Superparamagnetic Iron Oxide Nanoparticle: Intravenous Versus Intraperitoneal Approach.
Jung CS; Heine M; Freund B; Reimer R; Koziolek EJ; Kaul MG; Kording F; Schumacher U; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Invest Radiol; 2016 Mar; 51(3):194-202. PubMed ID: 26674208
[TBL] [Abstract][Full Text] [Related]
18. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
[TBL] [Abstract][Full Text] [Related]
19. The biological activity of cationic liposomes in drug delivery and toxicity test in animal models.
Qi P; Cao M; Song L; Chen C; Liu M; Li N; Wu D; Peng J; Hu G; Zhao J
Environ Toxicol Pharmacol; 2016 Oct; 47():159-164. PubMed ID: 27694054
[TBL] [Abstract][Full Text] [Related]
20. Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer.
Kim SY; Lee SJ; Kim JK; Choi HG; Lim SJ
Int J Nanomedicine; 2017; 12():7323-7335. PubMed ID: 29070949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
